Literature DB >> 8606383

Alcoholism: independent predictor of survival in patients with head and neck cancer.

F W Deleyiannis1, D B Thomas, T L Vaughan, S Davis.   

Abstract

BACKGROUND: Despite recognition of the high prevalence of alcoholism among patients with head and neck cancer, the prognostic importance of alcoholism has not been evaluated adequately. Previous investigators have speculated that alcoholic patients may have a poorer prognosis than nonalcoholic patients because of more advanced stage of cancer, the immunosuppressive effects of alcohol, and an increased rate of death due to other alcohol-related diseases.
PURPOSE: The goal of this population-based study was to identify the features of alcoholism that are associated with survival for patients with head and neck cancer and to develop an alcoholic severity staging system from a composite of the independent features of alcoholism.
METHODS: This prospective study included 649 patients who were diagnosed with cancer of the oral cavity, oropharynx, hypopharynx, or larynx during the period from September 1, 1983, through February 28, 1987, in a three-county area of western Washington state that participates in the Surveillance, Epidemiology, and End Results Program of the U.S. National Cancer Institute. Details on lifetime alcohol consumption, treatment for alcoholism, abstinence from alcohol prior to the diagnosis of cancer, and alcohol-related health problems were ascertained through in-person interviews near the time of diagnosis. Patients were classified as either nonalcoholics or alcoholics according to their responses to questions from the Michigan Alcoholism Screening Test. The measures of alcohol consumption and abuse that were found to be independently associated with 5-year survival by logistic regression analysis were combined using conjunctive consolidation to create a final composite variable, called an alcoholic severity stage. Cox proportional hazards regression analysis was done to estimate the relative risk (R) of death within 5 years due to specific causes of death for each of the alcoholic severity stages.
RESULTS: Alcoholism (RR = 2.06; 95% confidence interval [CI] = 1.43-2.98) and a history of alcohol-related systemic health problems (i.e., liver disease, pancreatitis, delirium tremens, or seizures) (RR = 2.76; 95% CI = 1.69-4.49) were associated with an increased risk of death, whereas abstinence (i.e., the consumption of fewer than one drink per week at 1 year prior to the diagnosis of cancer) (RR = 0.62; 95% CI = 0.39-0.97) was associated with a decreased risk of death. These associations were independent of age, site of cancer, anatomical stage, histopathologic grade, smoking, and type of antineoplastic treatment. Patients in the two worst alcoholic severity stages had an increased risk of dying not only of head and neck cancer but also of cardiovascular disease, pulmonary disease, and other alcohol-related causes.
CONCLUSIONS: Alcohol abuse, measured by alcohol consumption, functional impairment, a history of alcohol-related health problems, or abstinence, can provide important prognostic information for patients with head and neck cancer. Our results suggest that sobriety among alcoholic patients can lead to prolonged survival.

Entities:  

Mesh:

Year:  1996        PMID: 8606383     DOI: 10.1093/jnci/88.8.542

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  31 in total

1.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

Review 2.  Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Authors:  Jay F Piccirillo; Anna Vlahiotis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

3.  Comparison of Clinical Outcomes Following Head and Neck Surgery Among Patients Who Contract to Abstain From Alcohol vs Patients Who Abuse Alcohol.

Authors:  Azeem S Kaka; Songzhu Zhao; Enver Ozer; Amit Agrawal; Stephen Kang; James Rocco; Ricardo Carrau; Theodoros Teknos; John D Clapp; Harrison Weed; Matthew O Old
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

4.  Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer.

Authors:  Sonia A Duffy; Angela L Scheumann; Karen E Fowler; Cynthia Darling-Fisher; Jeffrey E Terrell
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

5.  Course of psychiatric comorbidity and utilization of mental health care after laryngeal cancer: a prospective cohort study.

Authors:  J Keszte; H Danker; A Dietz; E Meister; F Pabst; O Guntinas-Lichius; J Oeken; S Singer; A Meyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-15       Impact factor: 2.503

6.  Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control.

Authors:  A J Christensen; P J Moran; S L Ehlers; K Raichle; L Karnell; G Funk
Journal:  J Behav Med       Date:  1999-10

7.  European white paper: oropharyngeal dysphagia in head and neck cancer.

Authors:  Laura W J Baijens; Margaret Walshe; Leena-Maija Aaltonen; Christoph Arens; Reinie Cordier; Patrick Cras; Lise Crevier-Buchman; Chris Curtis; Wojciech Golusinski; Roganie Govender; Jesper Grau Eriksen; Kevin Hansen; Kate Heathcote; Markus M Hess; Sefik Hosal; Jens Peter Klussmann; C René Leemans; Denise MacCarthy; Beatrice Manduchi; Jean-Paul Marie; Reza Nouraei; Claire Parkes; Christina Pflug; Walmari Pilz; Julie Regan; Nathalie Rommel; Antonio Schindler; Annemie M W J Schols; Renee Speyer; Giovanni Succo; Irene Wessel; Anna C H Willemsen; Taner Yilmaz; Pere Clavé
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-12-19       Impact factor: 2.503

8.  Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx.

Authors:  Susan T Mayne; Brenda Cartmel; Victoria Kirsh; W Jarrard Goodwin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use.

Authors:  Henrique A Parsons; Marvin Omar Delgado-Guay; Badi El Osta; Ray Chacko; Valerie Poulter; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

Review 10.  Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine.

Authors:  M Bryant Howren; Alan J Christensen; Lucy Hynds Karnell; Gerry F Funk
Journal:  J Consult Clin Psychol       Date:  2012-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.